Balansag, Rodelia B.
HRN: 08-69-08 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/11/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/11/2024
07/24/2024
IVT
2.25 G
Q8h
Infected Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes